Workshop on Pharmacogenomics: from science to clinical care Session - PowerPoint PPT Presentation

Aug 28, 2023 •31 likes •61 views

Workshop on Pharmacogenomics: from science to clinical care Session 4 : Pharmacogenomics guided treatments in clinical care: experience from patients and healthcare professionals London, October 8-9, 2012 David H.-U. Haerry, EATG

Workshop on Pharmacogenomics: from science to clinical care Session 4 : Pharmacogenomics guided treatments in clinical care: experience from patients and healthcare professionals London, October 8-9, 2012 David H.-U. Haerry, EATG
✔ Pharmacogenomics in HIV/HCV A lot of experience accumulated ✓ Hypersensitivity testing pre-abacavir use (HLA B*5701 genetic test) ✓ IL28B polymorphism (HCV) ✓ Studies show genetic factors influence plasma concentrations in NNRTI (983T>C genotypes) ✓ Tropism testing pre-maraviroc use
✔ Areas of urgent improvement ✓ Pharmacogenetic testing to be an option in phIII pivotal trials for cases of hepatoxicity, hypersensitivity, rash – address IC, data protection ✓ Interpretation pharmacogenetic testing ✓ Regulatory differences FDA/AUS/EMA when better assays become available – case of Maraviroc

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Session 3: Post-approval pharmacogenomics: impact on Risk Management Workshop on

Session 3: Post-approval pharmacogenomics: impact on Risk Management Workshop on Pharmacogenomics: from Science to clinical care 8 October 2012 Presented by: Isabelle Moulon Head of Medical Information An agency of the European Union

239 views • 8 slides

Genomics in Patients with Hispanic ancestry - Pharmacogenetics in Hispanics and Its clinical

EMA Workshop on Pharmacogenomics: from science to clinical care October 8-9, 2012 Genomics in Patients with Hispanic ancestry - Pharmacogenetics in Hispanics and Its clinical implications - Adrin LLerena MD PhD Clinical Research Centre

339 views • 29 slides

Elisabeth George, Technology Appraisals Centre for Health Technology Evaluation, NICE Workshop on

HTA of Companion Diagnostics Elisabeth George, Technology Appraisals Centre for Health Technology Evaluation, NICE Workshop on Pharmacogenomics: from science to clinical care 8-9 October 2012 European Medicines Agency, London, United Kingdom

411 views • 23 slides

Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies Mike

Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies Mike Pacanowski, PharmD, MPH Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research U.S. Food and Drug

659 views • 26 slides

Evaluation & Implementation Challenges with Genomic Signatures in Clinical Drug Development

April 3-4, 2006 Evaluation & Implementation Challenges with Genomic Signatures in Clinical Drug Development V. Devanarayan, Ph.D. Exploratory Statistics, Pharmaceutical R&D Abbott EMA Workshop on Pharmacogenomics: From Science to

572 views • 18 slides

Differences in a biomarkers predictive ability across racial groups Steve Lewitzky, Novartis

Differences in a biomarkers predictive ability across racial groups Steve Lewitzky, Novartis Pharmaceuticals EMA Workshop on Pharmacogenomics: from science to clinical care October 9, 2012 Overview Introduction: Differences in

465 views • 17 slides

PHARMACOGENOMICS AN INTRODUCTION TO PERSONALIZED MEDICINE Megan Penner-Willis, PharmD Clinical

PHARMACOGENOMICS AN INTRODUCTION TO PERSONALIZED MEDICINE Megan Penner-Willis, PharmD Clinical Assistant Professor UAA/ISU Doctor of Pharmacy Program DISCLOSURES I do not have (nor does any immediate family member have) a vested interest in

554 views • 37 slides

Regulation, innovation and personalised medicine The governance of pharmacogenomics in Europe

Regulation, innovation and personalised medicine The governance of pharmacogenomics in Europe and the USA Presentation at EMA workshop, London, October 2012 Dr Stuart Hogarth Department of Social Science, Health and Medicine, Kings College

243 views • 22 slides

Pharmacogenomics: Regulatory Considerations for the Next Generation of Medicines Hobart Rogers,

Pharmacogenomics: Regulatory Considerations for the Next Generation of Medicines Hobart Rogers, Pharm.D., Ph.D., Genomics and Targeted Therapies Group Office of Clinical Pharmacology FDA The views expressed are those of the speakers and do

769 views • 60 slides

Pharmacogenomics: Providing Personalized Medicine April 28, 2020 Russ B. Altman, PhD, MD

Pharmacogenomics: Providing Personalized Medicine Pharmacogenomics: Providing Personalized Medicine April 28, 2020 Russ B. Altman, PhD, MD Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy)

846 views • 23 slides

The College of St. Scholastica, Duluth, MN Background We need to move the pharmacogenomics

Strategies for Infusing Pharmacogenomics into NP Education Sara McCumber, DNP, APRN, CNP, CNS The College of St. Scholastica, Duluth, MN Background We need to move the pharmacogenomics conversation beyond grapefruit juice and simvastatin!!! The

340 views • 3 slides

Informatics challenges for pharmacogenomics Russ B. Altman, MD, PhD Departments of

Informatics challenges for pharmacogenomics Russ B. Altman, MD, PhD Departments of Bioengineering & Genetics PharmGKB, http://www.pharmgkb.org/ Stanford University Four stories about pharmacogenomics 1. Building a knowledge repository for

847 views • 72 slides

Pharmacogenomics as a proof of principal for genomic medicine: emphasis on real endpoints

Pharmacogenomics as a proof of principal for genomic medicine: emphasis on real endpoints December 5, 2011 Dr Howard L. McLeod Eshelman Distinguished Professor and Director Institute for Pharmacogenomics and Individualized Therapy (IPIT)

405 views • 24 slides

12 th International IACFS/ME Conference Emerging Science & Clinical Care Ft. Lauderdale,

12 th International IACFS/ME Conference Emerging Science & Clinical Care Ft. Lauderdale, October 27-30, 2016 One Persons Highlights of the Biological Research Presentations Anthony L. Komaroff, M.D. Since the 2014 San Francisco Meeting

604 views • 28 slides

Integrating Pharmacogenomics into Decision Making Munir Pirmohamed David Weatherall Chair of

Integrating Pharmacogenomics into Decision Making Munir Pirmohamed David Weatherall Chair of Medicine and NHS Chair of Pharmacogenetics Department of Molecular and Clinical Pharmacology Institute of Translational Medicine University of

337 views • 22 slides

Clinical view on current Standard of Care in NMO R. MARIGNIER MD, PhD Service de Neurologie A et

Regulatory Workshop on Clinical Trials Designs in Neuromyelitis Optica (NMO) and Spectrum Disorders Clinical view on current Standard of Care in NMO R. MARIGNIER MD, PhD Service de Neurologie A et Centre de Coordination EDMUS sur la Sclrose en

394 views • 23 slides

PGx Test: A Life Saver Personalized Medicine for Everyone Current Prescriptions Take

PGx Test: A Life Saver Personalized Medicine for Everyone Current Prescriptions Take this, if it doesnt work, well try something else. TRADITIONAL TREATMENT Traditional testing results in a one size fits all approach

731 views • 30 slides

Sta tate str trategie ies of governance in in global l biomedical innovation: the the impact

Sta tate str trategie ies of governance in in global l biomedical innovation: the the impact of Chi hina a and In India ESRC Rising P Powers p proj ojec ect 2 2012-20 2015 Aim To examine the nature and impact of China and Indias

271 views • 11 slides

HealthGrid and S HARE: retrospect and prospect for grids in health Yannick Legr (HealthGrid)

HealthGrid and S HARE: retrospect and prospect for grids in health Yannick Legr (HealthGrid) on behalf of the S HARE Consortium http:/ / www.eu-share.org S lides credit: Tony S olomonides http:/ / www.healthgrid.org S HARE: S

497 views • 27 slides

Role of genomics in pharmacovigilance prof. MUDr. Ond ej Slana , Ph.D. Daepartment of

Role of genomics in pharmacovigilance prof. MUDr. Ond ej Slana , Ph.D. Daepartment of Pharmacology, 1st Faculty of Medicine, Charles University in Prague General Teaching Hospital, Prague 1 2 The Wall Street Journal, Friday, April 16,

795 views • 37 slides

EFLM represents IFCC in Europe

www.efcclm.eu www.efcclm.eu EFLM represents IFCC in Europe

732 views • 18 slides

PDUFA PDUFA-V PDUFA PDUFA-V V V Confidential Do not distribute Overview of PDUFA-V

As Presented at the NCCS Cancer Policy Roundtable By Dr. David E. Wheadon October 18-19, 2011 PDUFA PDUFA-V PDUFA PDUFA-V V V Confidential Do not distribute Overview of PDUFA-V Proposals Basic structure of the human drug review

193 views • 4 slides

IFCC Awards for 2017 Howard Morris Chair IFCC Awards Committee 2015- 2017 IFCC Awards

IFCC Awards for 2017 Howard Morris Chair IFCC Awards Committee 2015- 2017 IFCC Awards Committee membership Howard Morris, Chair (AU) Larry Kricka (US) Muhidien Jouma (SY) Leslie Lai (MY) Grazyna Sypniewska (PL) Vanessa Steenkamp (ZA)

341 views • 12 slides

Disclaimer: Presentation slides from the Rare Disease Workshop Series are posted by the EveryLife

Disclaimer: Presentation slides from the Rare Disease Workshop Series are posted by the EveryLife Foundation for Rare Diseases for educational purposes only. They are for use by drug development professionals and statisticians, and are not to

482 views • 15 slides